These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16609910)

  • 1. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms.
    Tatsumi N; Kushima R; Vieth M; Mukaisho K; Kakinoki R; Okabe H; Borchard F; Stolte M; Okanoue T; Hattori T
    Virchows Arch; 2006 Jun; 448(6):756-62. PubMed ID: 16609910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
    Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
    Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma.
    Bruewer M; Schmid KW; Krieglstein CF; Senninger N; Schuermann G
    World J Surg; 2002 Jun; 26(6):726-31. PubMed ID: 12053227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
    Zhao SM; Zhu XZ; Ji Y; Hou J
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
    Sato A; MacHinami R
    Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases.
    Tatsumi N; Mukaisho K; Mitsufuji S; Tatsumi Y; Sugihara H; Okanoue T; Hattori T
    Dig Dis Sci; 2005 Sep; 50(9):1741-6. PubMed ID: 16133982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis.
    Chang HJ; Kim SW; Lee BL; Hong EK; Kim WH
    Pathol Int; 2004 Aug; 54(8):576-84. PubMed ID: 15260848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell change in colonic tubular adenoma and corresponding colonic clear cell adenocarcinoma is associated with an altered mucin core protein profile.
    Shi C; Scudiere JR; Cornish TC; Lam-Himlin D; Park JY; Fox MR; Montgomery EA
    Am J Surg Pathol; 2010 Sep; 34(9):1344-50. PubMed ID: 20697252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
    Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
    Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histomorphologic and molecular features of pouch and peripouch adenocarcinoma: a comparison with ulcerative colitis-associated adenocarcinoma.
    Jiang W; Shadrach B; Carver P; Goldblum JR; Shen B; Liu X
    Am J Surg Pathol; 2012 Sep; 36(9):1385-94. PubMed ID: 22895272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum.
    Kim DH; Kim JW; Cho JH; Baek SH; Kakar S; Kim GE; Sleisenger MH; Kim YS
    Int J Oncol; 2005 Oct; 27(4):957-64. PubMed ID: 16142311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlation of expression of L-type amino-acid transporter 1 with colorectal tumor progression and prognosis: Higher expression in sporadic colorectal tumors compared with ulcerative colitis-associated neoplasia.
    Sakata T; Hana K; Mikami T; Yoshida T; Endou H; Okayasu I
    Pathol Res Pract; 2020 Jun; 216(6):152972. PubMed ID: 32359697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
    Gui X; Liu S; Yan Y; Gao Z
    World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin.
    Resto VA; Krane JF; Faquin WC; Lin DT
    Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):59-64. PubMed ID: 16466101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.